- Filed
- Apr 29, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · Apr 22, 2025 | 17.25M sh |
| Long Term Debt | Q1 2025 · Mar 31, 2025 | $561.51M |
| Long Term Debt | Q1 2025 · Dec 31, 2024 | $342.86M |
| Short Term Debt | Q1 2025 · Mar 31, 2025 | $13.75M |
| Short Term Debt | Q1 2025 · Dec 31, 2024 | $13.75M |
| Cash And Equivalents | Q1 2025 · Mar 31, 2025 | $23.38M |
| Cash And Equivalents | Q1 2025 · Dec 31, 2024 | $21.91M |
| Current Liabilities | Q1 2025 · Mar 31, 2025 | $211.49M |
| Current Liabilities | Q1 2025 · Dec 31, 2024 | $338.82M |
| Current Assets | Q1 2025 · Mar 31, 2025 | $439.97M |
| Current Assets | Q1 2025 · Dec 31, 2024 | $409.12M |
| Total Assets | Q1 2025 · Mar 31, 2025 | $1.36B |
| Total Assets | Q1 2025 · Dec 31, 2024 | $1.34B |
| Shares Diluted | Q1 2025 · Mar 31, 2024 | 18.94M sh |
| Stock Repurchased | Q1 2025 · Mar 31, 2024 | $61M |
| Capex | Q1 2025 · Mar 31, 2024 | $1.19M |
| Operating Cash Flow | Q1 2025 · Mar 31, 2024 | −$130.72M |
| Stockholders Equity | Q1 2025 · Mar 31, 2024 | $495.61M |
| Stockholders Equity | Q1 2025 · Dec 31, 2023 | $532.89M |
| Eps Diluted | Q1 2025 · Mar 31, 2024 | $0.95 |
| Eps Basic | Q1 2025 · Mar 31, 2024 | $0.99 |
| Sga Expense restated | Q1 2025 · Mar 31, 2024 | $72.7M |
| Net Income | Q1 2025 · Mar 31, 2024 | $18.01M |
| Operating Income | Q1 2025 · Mar 31, 2024 | $19.92M |
| Revenue | Q1 2025 · Mar 31, 2024 | $363.39M |